Aerie Pharmaceuticals reported $6.07M in Cost of Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Aerie Pharmaceuticals AERI:US $ 6.07M 1.83M
Alimera Sciences ALIM:US $ 1.97M 0.28M
Novartis NOVN:VX SF 4000M 152M
Valeant Pharmaceuticals VRX:CN $ 626M 44M
Zoetis ZTS:US $ 596M 14M